Skip to main content
Clinical Trials/NCT04702100
NCT04702100
Completed
Not Applicable

Instrument-assisted Soft Tissue Mobilization Versus Integrated Neuromuscular Inhibition Technique on Mechanical Non-specific Neck Pain

Cairo University1 site in 1 country90 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non-specific Chronic Mechanical Neck Pain
Sponsor
Cairo University
Enrollment
90
Locations
1
Primary Endpoint
pain intensity
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

the aim of this study is to investigate the efficacy of instrumented assisted soft tissue mobilization versus integrated neuromuscular inhibition technique on mechanical non-specific neck pain

Detailed Description

Mechanical neck pain is a prevalent condition in various populations. Neck pain occurrence is affected by several factors, involving environmental, psychological, and social aspects. Neck pain represents the fourth major disorder responsible for a person's year lived with disability and ranked eleventh as disability-adjusted life years of a person. The neck pain incidence ranges from 10.4 to 23.3% in 1-year time, while the range of prevalence was 0.4 to 86.8%. It has a high prevalence among computer users, office workers, and females, especially females aged 35 to 49 years old. Myofascial trigger point (MTrP) might play an important role in the formation of mechanical neck pain and is known as a hyperirritable spot in skeletal muscle that is accompanied with a hypersensitive palpable nodule in a taut band. IASTM and integrated play an important role in the treatment of mechanical neck pain.this trial has three groups; one will receive IASTM+ conventional, the second will receive integrated + conventional and the third will receive conventional treatment for four week

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
March 30, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Al Shaymaa Shaaban Abd El Azeim

principle investigator

Cairo University

Eligibility Criteria

Inclusion Criteria

  • diagnosed as non-specific neck pain with upper trapezius active myofascial trigger points less than 3 months of duration and have these criteria: taut band on palpation, hyper sensible tender spot in the taut band, local twitch response referred pain pattern
  • body mass index from 18 to 25 kg/m2
  • their ages from 18-35

Exclusion Criteria

  • if they had trigger point injections within the past 6 months
  • history of neck or upper back surgery, trauma or fracture
  • history of a whiplash injury, skin diseases and lesions, any sensory disturbances, any vascular syndromes, neck and back deformities
  • cervical radiculopathy, and diagnosis of fibromyalgia syndrome, skin diseases

Outcomes

Primary Outcomes

pain intensity

Time Frame: up to four weeks

The scale that will be used the VAS ;each subject will instructed to put point on line from no pain to tolerable pain

Secondary Outcomes

  • neck disability(up to four weeks)
  • muscle amplitude in the form of normalized root mean square (RMS)(up to four weeks)
  • muscle fatigue in the form of median frequency(up to four weeks)

Study Sites (1)

Loading locations...

Similar Trials